1325 related articles for article (PubMed ID: 26074711)
1. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
2. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization.
Keshavamurthy S; Koch CG; Fraser TG; Gordon SM; Houghtaling PL; Soltesz EG; Blackstone EH; Pettersson GB
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3157-65.e1-5. PubMed ID: 25242055
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
8. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
Mamic P; Heidenreich PA; Hedlin H; Tennakoon L; Staudenmayer KL
J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
[TBL] [Abstract][Full Text] [Related]
9. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
Pakyz AL; Jawahar R; Wang Q; Harpe SE
J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States.
Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
[TBL] [Abstract][Full Text] [Related]
12. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
[TBL] [Abstract][Full Text] [Related]
15. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
Stevens V; Dumyati G; Brown J; Wijngaarden E
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
[TBL] [Abstract][Full Text] [Related]
16. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
17. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).
Ticinesi A; Nouvenne A; Folesani G; Prati B; Morelli I; Guida L; Turroni F; Ventura M; Lauretani F; Maggio M; Meschi T
BMJ Open; 2015 Oct; 5(10):e009316. PubMed ID: 26503394
[TBL] [Abstract][Full Text] [Related]
20. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.
Pant C; Anderson MP; O'Connor JA; Marshall CM; Deshpande A; Sferra TJ
Transpl Infect Dis; 2012 Oct; 14(5):540-7. PubMed ID: 22726461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
